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The Brazilian Nationwide Population Screening Program for Diabetes, conducted in 2001, diagnosed 346,168 new cases. Although
unexpected, approximately 65,000 previously diabetic individuals participated. We describe their characteristics compared to new
cases, based on data obtained by a follow-up study of a subsample of 4991 positively screened from a representative sample
of 90,106 individuals. Two groups were analyzed regarding factors associated with adherence to treatment, healthcare services
utilization, and compliance to pharmacological treatment: 497 with newly diagnosed diabetes and 257 individuals with previous
diabetes diagnosis who were not under treatment at the screening program. For this group, healthcare service utilization was lower
when compared with the new cases (OR = 0.06; 95% CI: 0.03–0.12). Diabetes status (OR = 0.23; 95% CI: 0.14–0.37), a healthy
behavior score (OR = 0.53, 95% CI: 0.34–0.83), and glucose levels at screening (altered, OR = 5.01; 95% CI: 2.38–10.6 and likely
a n dv e r yl i k e l yD MO R= 11.2; 95% CI: 6.85–18.4) were independently associated with pharmacological treatment.
1.Introduction
Worldwide, the prevalence of diabetes mellitus (DM) con-
tinuous to rise, being an international health burden (1).
The increase of individuals with DM is expected to happen
mainly in developing countries due to the growth and
aging of populations, urbanization, obesity, and sedentary
behavior [1–3]. In Brazil a 69% increase in the number of
peoplewithdiabetesfortheyear2030isestimated,compared
to 2000 [4].
In 2001, the Brazilian Ministry of Health, with the
collaboration of state and municipal health authorities and
medical societies, implemented a National Campaign for the
Reorganization of Diabetes Mellitus Care (CNDDM) [5].
TheBrazilianNationwidePopulationScreeningProgram
for Diabetes (BNPSPD), was one of several components of
the National Plan, being conducted through primary health-
care services during March 6th and April 7th, 2001 and have
been previously described [5, 6]. Brieﬂy, all Brazilian citizens
aged 40 or older were invited to participate, and 22.069,905
capillaryglucosetestswereperformed,ofwhich15.48%were
considered positive (fasting capillary glucose ≥ 100mg/dL
or casual glucose ≥ 140mg/dL). Screening was performed
in a “campaign” style, in which the population was called
for primary health care services in a short period of time to
perform screening tests [7, 8].
This study was proposed considering the magnitude of
the results obtained in the BNPSPD and the diﬃculties
perceived and presented in other investigations [9–12]s u c h
as adherence to treatment and healthy behavior in chronic
disease. The main objective of this study was to describe
a group of individuals who were not investigated in the
literature so far: those who were identiﬁed as having diabetes
diagnosis during the BNPSPD have reported having this
diagnosis prior to screening and, despite this diagnosis,
they were not under medical treatment. We also aimed to2 ISRN Endocrinology
identify factors associated to healthcare services utilization
and compliance to pharmacological treatment in those
individuals compared to newly diagnosed DM cases.
2. Methods
A detailed description of the follow-up study of individ-
uals positively screened during the screening program is
described in detail elsewhere [8, 11]. In summary, from a
follow-up study of a representative stratiﬁed random sample
of90,106asubsampleof4991positivelyscreenedindividuals
was actively followed up through home interviews which
wereperformedbytrainedprofessionalsusingastandardized
questionnaire15to19monthsafterscreening.Thequestion-
naire included 43 questions on demographics, BNPSPD par-
ticipation, diagnostic conﬁrmation, and orientation received
and adopted to treat diabetes, laboratory tests, therapy and
use of medications, and followup in healthcare services.
Among 4991 (Figure 1) participants that were inter-
viewed and that had positive screening tests, 85 were
deceased at the moment of the follow-up study and the 394
who did not remember participating in the CNDDM were
excluded. Of the 4512 remaining individuals, 786 declared
that they knew that they were diabetic at the screening, with
257 conﬁrmed as diabetics that did not treat the condition.
Among the 3726 participants that were alive, remembered
CNDDM participation, and were not previously diabetic,
1822 were submitted to tests and 469 had their diabetes
conﬁrmed. An additional 28 individuals had their diabetes
conﬁrmed by a combination of medical assistance in emer-
gency conditions and a high blood glucose level during
the screening, for a total of 497 new cases detected (NCD,
reference group). Therefore, two groups were formed for
analysis: new cases (497) and previously diabetic individuals
that were not under treatment (PDWIT, 257). This group
was deﬁned as those that declared not to be treating diabetes
in the CNDDM and declared, at the active surveillance, that
they knew they were diabetic before the screening.
For the screening program, standardization and classiﬁ-
cation were deﬁned for tests results according to which rec-
ommendations were made to individuals who participated
varying from repeat test in 3 years to immediate consultation
with physician (Table 1). For the purposes of this study,
individuals presenting glucose blood tests at the level of
likely (fasting or casual ≥ 200) or very likely (fasting or
casual ≥ 270mg/dL) diabetes at screening and those who
had a conﬁrmatory test were considered having diabetes. No
additional biochemical assessments were done in patients,
except for glucose testing. A third group of 318 previously
diabetic individuals that had their diagnoses conﬁrmed was
excluded from this study because participants declared to
be treating their diabetes before CNDDM, although in the
form at screening they declared that they did not treat the
condition (11).
Gender, age, schooling, glucose blood test result in the
program, adhesion to pharmacological and nonpharma-
cological treatment for diabetes, and health care services
utilization were analyzed. Individuals who informed to be
under medical followup were considered utilizing health
care services. In order to quantify adherence to non-
pharmacological recommendations, a numeric score (from
0–7) was developed in which one point was given to each
healthy behavior referred by the individual: weight control,
ingestion of food with low levels or no salt, preference to
low-fat food, ingestion of fruits or vegetables at least twice
a day, avoiding or not smoking, regular physical activity,
and monitoring glycemic levels at least once every three
years.
All data were collected on standardized forms, double
entered into an electronic database, and analyzed using
the survey data analysis function of STATA, version 8.2.
Univariate analysis was performed considering the sampled
primary healthcare units (PHUs) as the basic unit of the
conglomerate (PSU, primary strata unit) while subnational
regions were considered as the strata. Odds ratios and 95%
conﬁdence intervals were estimated for variables analyzed.
All variables signiﬁcantly associated with healthcare services
utilization and compliance to pharmacological treatment in
bivariate analysis (P ≤ 0.05) were included in the logistic
regression model.
3. Results
A total of 497 individuals in the NCD group (control group)
and 257 individuals in the PDIWT group were analyzed.
The majority of the individuals analyzed in both groups
were women (56.3% in NCD group and 57.2% in PDIWT
group; Table 2). In the NCD group, a higher proportion of
individuals were 50–59 years old, whereas in the PDIWT
group, individuals were equally distributed in the 40–49-
years (29.2%) and 60–69-years (29.6%) age groups. The
blood glucose test conﬁrmatory demonstrated levels of likely
or very likely DM in 57.3% of NCD; on the other hand,
72.0%ofPDWIThadaborderlinebloodglucoseresult.Most
individuals in both groups had a health behavior score <4
(81.3% and 79.0% for new cases and previously diabetic,
resp.; Table 2).
Among the NCD groups, 92.2% individuals referred
utilization of health care services, signiﬁcantly higher pro-
portion than among the PDWIT group (33.1%; P<0.001).
Table 3 details service utilization and pharmacological treat-
ment in the two groups. In the group of NCD, blood glucose
levels were associated with pharmacological treatment for
diabetes (P<0.001). In the PDWIT group, the outcomes
of health care services utilization and pharmacological
treatment were associated with the health behavior score
(P<0.05) and blood glucose levels in the screening program
(P<0.001).
When variables signiﬁcantly associated to the evaluated
outcomes in bivariate analysis (P<0.05) were entered into
a logistic regression model, and considering the NDC group
as reference, the only factor signiﬁcantly associated to health
care services utilization was diabetes status (OR = 0.06; 95%
CI: 0.03–0.13; Table 4).
Factors signiﬁcantly associated to pharmacological treat-
ment were diabetes status (OR = 0.23; 95% CI: 0.14–0.37),
healthy behavior score of 4 or higher (OR = 0.53; 95%
CI: 0.34–0.83), altered blood glucose level (OR = 5.01;ISRN Endocrinology 3
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Figure 1:SampleofpositivelyscreenedindividualsduringtheBNPSPD,includedinthefollow-upstudy,Brazil,2002.DM,diabetesmellitus;
BNPSPD: Brazilian Nationwide Population Screening Program for Diabetes.
Table 1: Classiﬁcation of screening test results and recommendations made to individuals who participated in the BNPSPD, brazil, 2001.
mg/dL Categories Recommendation
Fasting capillary glucose
<100 Normal Repeat test in 3 years
100 to 125 Borderline Schedule future appointment
126 to 199 Altered Order fasting serum glucose and recommend return medical appointment
≥200 Likely DM Order fasting serum glucose and schedule future appointment
≥270 Very likely DM Immediate consultation with physician
Nonfasting capillary glucose
<140 Normal Repeat test in 3 years
140 to 199 Borderline Schedule future appointment
≥200 Likely DM Order fasting serum glucose and recommend return medical appointment
≥270 Very likely DM Immediate consultation with physician
BNPSPD: Brazilian Nationwide Population Screening Program for Diabetes.
95% CI: 2.38–10.57), and blood glucose in the level of likely
and very likely diabetes (OR = 11.22; 95% CI: 6.85–18.40;
Table 4).
4. Discussion
The Brazilian Ministry of Health implemented the National
Program of Detection of Diabetes Mellitus as a component
of the Plan for the Care of Diabetes and Hypertension,
recognizingthattheearlyidentiﬁcation,assistance,followup
of people with diabetes, and health care service utilization in
the basic health units are crucial elements to health control.
It was also recognized that assistance was not systematic in
the country [5, 7, 8, 11].
The participation of previously diabetic individuals in
the screening program showed the need for a better under-
standing of the components involved and possible inﬂuence
in health service utilization. A possible explanation to justify
this may be related to diﬃculties in the management of
the disease and its treatment [13–15], or problems in the4 ISRN Endocrinology
Table 2: Clinical and demographic characteristics of BNPSPD participants considering the two groups analyzed. Brazil, 2001.
New cases (NCD) Previously diabetic individuals without treatment
(PDWIT)
N = 497 N = 257
(%) (%)
Gender
Male 217 (43.7) 110 (42.8)
Female 280 (56.3) 147 (57.2)
Age (years)
40–49 127 (25.6) 75 (29.2)
50–59 160 (32.2) 69 (26.8)
60–69 131 (26.4) 76 (29.6)
70 or more 79 (15.9) 37 (14.4)
Schooling
Illiterate 121 (24.6) 55 (21.5)
Elementary education incomplete 282 (57.4) 139 (54.3)
Elementary education complete or + 88 (17.9) 62 (24.2)
Region
North 22 (4.4) 17 (6.6)
Northeastern 138 (27.8) 44 (17.1)
Midwestern 28 (5.6) 24 (9.3)
Southeastern 236 (47.5) 119 (46.3)
South 73 (14.7) 53 (20.6)
Glucose level∗
Borderline 137 (27.6) 185 (72.0)
Altered 75 (15.1) 18 (7.0)
Likely and very likely 285 (57.3) 54 (21.0)
Healthy score
<4 404 (81.3) 203 (79.0)
≥4 93 (18.7) 54 (21.0)
∗Borderline ≥ 100 < 126mg/dL, altered ≥ 126 < 200mg/dL, likely and very likely ≥200mg/dL.
BNPSPD: Brazilian Nationwide Population Screening Program for Diabetes.
understanding of the disease itself [15], considering the
low schooling of the population. The possibility that these
individuals had taken part as a way to control glucose levels
must be considered as wellas occasional ﬂawsin fulﬁllingthe
form.
In both groups, females, individuals with incomplete
elementary schooling, and those of 50–69 years of age
predominated. The age of individuals that were not under
treatment was similar to those considered new cases. For
variables such as gender and age, results are in accordance
with the observations of other studies [2, 3].
Most of the individuals presented less than four healthy
behaviors (81.3% and 79.0%, NCD and PDWIT, resp.)
demonstrating diﬃculties to establish and to keep non-
pharmacological procedures.
T h ea n a l y s i so fd e m o g r a p h i cv a r i a b l e si nt h ep r o c e s so f
adhesion and health service utilization does not show results
that may point out a speciﬁc proﬁle of individuals. Accord-
ing to results of bivariate analysis, the only variable that
reached statistical signiﬁcance was schooling, considering
pharmacological treatment as the outcome. However, health
system utilization in this study, as in others [10, 16], was not
inﬂuenced by age, gender, and schooling.
Health care service utilization was signiﬁcantly higher
among NCD, showing that the objective diagnosis and
service utilization is achieved. If health care utilization was
lower among PDIWT, special strategies should be necessary
in this group in order to include them in the health system.
The healthy behavior score and blood glucose levels in the
screening were also associate to health service utilization in
the bivariate analysis; however the association disappeared
after logistic regression.
According to multivariate analysis, PDIWT group
presents 23% of the chance of an NCD to treat the condition
and has a healthy behavior score <4 corresponding to a
53% chance of pharmacologically treating the condition
compared to individuals with four or more healthy behav-
iors. These data indicate a strong relationship between
the acquisition and maintenance of healthy behaviors and
the treatment of diabetes. The pharmacological treatmentISRN Endocrinology 5
Table 3: Comparison of factors potentially associated to healthcare service utilization and pharmacological treatment in the two groups
analyzed. Brazil, 2001.
New cases Previously diabetic individuals without treatment
(NCD) (PDWIT)
Service utilization Pharmacological
treatment Service utilization Pharmacological
treatment
Gender
Male 197/217 (90.8) 168/217 (77.4) 41/110 (37.3) 39/110 (35.5)
Female 261/280 (93.2) 221/280 (78.9) 44/147 (29.9) 43/147 (29.3)
Age (years)
40–49 113/127 (89.0) 92/127 (72.4) 21/75 (28.0) 19/75 (25.3)
50–59 152/160 (95.0) 126/160 (78.7) 23/69 (33.3) 22/69 (31.9)
60–69 122/131 (93.1) 104/131 (79.4) 29/76 (38.2) 28/76 (36.8)
70 or more 71/79 (89.9) 67/79 (84.8) 12/37 (32.4) 13/37 (35.1)
Schooling
Illiterate 107/121 (88.4) 94/121 (77.7) 14/55 (25.5) 15/55 (27.3)
Elementary education incomplete 266/282 (94.3) 229/282 (81.2) 48/139 (34.5) 48/139 (34.5)
Elementary education completed or + 79/88 (89.8) 60/88 (68.2) 23/62 (37.1) 19/62 (30.6)
Healthy behaviour
Score <4 376/407 (93.1) 323/407 (80.0) 76/203 (37.4)+ 73/203 (36.0)+
Score ≥4 82/93 (88.2) 66/93 (71.0) 9/54 (16.7)+ 9/54 (16.7)+
Glucose level∗∗
Borderline 125/137 (91.2) 78/137 (56.9)∗ 25/185 (13.5)∗ 22/185 (11.9)∗
Altered 68/75 (90.7) 57/75 (76.0)∗ 17/18 (94.4)∗ 15/18 (83.3)∗
Likely and very likely DM 265/285 (93.0) 254/285 (89.1)∗ 43/54 (79.6)∗ 45/54 (83.3)∗
Region
North 19/22 (86.4) 13/22 (59.1) 9/17 (52.9) 8/17 (47.1)
Northeastern 118/138 (85.5) 103/138 (74.6) 11/44 (25.0) 12/44 (27.3)
Midwestern 27/28 (96.4) 24/28 (85.7) 8/24 (33.3) 9/24 (37.5)
Southeastern 226/236 (95.8) 193/236 (81.8) 39/119 (32.8) 38/119 (31.9)
South 68/73 (93.2) 56/73 (76.7) 18/53 (34.0) 15/53 (28.3)
+P < 0,05.
∗P < 0,001.
∗∗Borderline ≥ 100 < 126mg/dL, altered ≥ 126 < 200mg/dL likely and very likely ≥200mg/dL.






New cases 1 1
Previously diabetic individuals under treatment 0.06 (0.03–0.13) 0.23 (0.14−0.37)
Healthy behavior score
≥41 1
<4 0.62 (0.34–1.13) 0.53 (0.34–0.83)
G l u c o s el e v e la tt h es c r e e n i n g ∗
Borderline 1 1
Altered 2.22 (0.62–7.93) 5.01 (2.38−10.6)
Likely and very likely DM 1.20 (0.59–2.46) 11.2 (6.85−18.4)
∗Borderline ≥ 100 < 126mg/dL, altered ≥ 126 < 200mg/dL, likely and very likely ≥200mg/dL.6 ISRN Endocrinology
reaches a higher proportion of individuals with higher
blood glucose levels considering that these individuals tend
to be more symptomatic and, as a consequence, look for
treatment. It is, however, interesting to emphasize that, when
health service utilization is taken into consideration, glucose
levels and healthy behavior scores were not statistically
signiﬁcant.
Population-based studies on adhesion to treatment and
health service utilization are not explored in the literature,
making the importance of results of the program more
evident. In the present study, the variable actually associated
withhealthserviceutilizationwasthediagnosisofanewcase.
Possible limitations of this study must be considered.
Information was obtained in a self-referred process by
patients.Datawerenotdirectlyobtained,norameasurement
was done or other registers were simultaneously employed.
Other authors underscored this kind of limitation [17]. We
should also consider the possibility of some inadequacy in
the answers on the form to select individuals with diabetes,
causing problems in further orientations to this group. The
omission of this information may have occurred in order
to obtain a free glucose test. Another important point to
be considered is that, as mentioned by other authors [9],
in general individuals that do not adhere to components
of treatment tend to be more sincere. The period of time
between the program and the active surveillance (15 to 19
months) may have caused diﬀerences in the declarations.
There is the possibility of memory bias, since sick individuals
tend to better recall their behavior.
In summary, results obtained are in accordance with
those of the literature, showing that demographic variables
donotmakeaspeciﬁcproﬁleofadhesiontopharmacological
treatment and health service utilization. The greater service
utilization veriﬁed among NCD indicates a relevant result
of the National Plan and, particularly, of the Program, as
a screening strategy and further service utilization. Part
of the PDIWT group was recovered by the health system;
however, strategies specially directed to this group deserve
consideration. Importantly, the work developed in health
system by the available programs should be revisited and
optimized in order to obtain a better support for patients
with chronic diseases such as, according to this study,
diabetes.
References
[1] J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates
of the prevalence of diabetes for 2010 and 2030,” Diabetes
Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010.
[2] International Diabetes Federation, IDF Diabetes Atlas, Inter-
national Diabetes Federation, Brussels, Belgium, 4th edition,
2009.
[3] H. King, R. E. Aubert, and W. H. Herman, “Global burden
of diabetes, 1995–2025: prevalence, numerical estimates, and
projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431,
1998.
[4] S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global
prevalence of diabetes: estimates for the year 2000 and
projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–
1053, 2004.
[5] R. B. Barbosa, A. Barcelo, and C. A. Machado, “National
campaign to detect suspected diabetes cases in Brazil: a
preliminary report,” Revista Panamericana de Salud Publica,
vol. 10, no. 5, pp. 324–327, 2001.
[ 6 ]L .B .N u c c i ,C .M .T o s c a n o ,A .L .M a i ae ta l . ,“ An a t i o n w i d e
population screening program for diabetes in Brazil,” Revista
Panamericana de Salud Publica, vol. 16, no. 5, pp. 320–327,
2004.
[7] Plano de Reorganizac ¸˜ ao da Atenc ¸˜ ao ` aH i p e r t e n s ˜ ao Arterial e ao
Diabetes Mellitus: Hipertens˜ ao Arterial e Diabetes Mellitus, vol.
59 of S´ erie C. Projetos, Programas e Relat´ orios, Minist´ erio da
Sa´ ude, Bras´ ılia, Brazil, 2001.
[8] C. M. Toscano, B. B. Duncan, S. S. Mengue et al., “Initial
impact and cost of a nationwide population screening cam-
paign for diabetes in Brazil: a follow up study,” BMC Health
Services Research, vol. 8, pp. 189–191, 2008.
[9] E. Sabat´ e, Adherence to Long-Term Therapies: Evidence for
Action, WHO World Health Organization, Geneva, Switzer-
land, 2003.
[10] M. R. Di Matteo, “Variations in patients’ adherence to
medical recommendations: a quantitative review of 50 years
of research,” Medical Care, vol. 42, no. 3, pp. 200–209, 2004.
[11] Avaliac ¸˜ ao do Plano de Reorganizac ¸˜ ao da Atenc ¸˜ ao ` aH i p e r t e n s ˜ ao
ea oD i a b e t e sM e l l i t u sn oB r a s i l , Minist´ erio da Sa´ ude, Bras´ ılia,
Brazil, 2004.
[12] M. R. Di Matteo, K. B. Haskard, and S. L. Williams, “Health
beliefs, disease severity, and patient adherence: a meta-
analysis,” Medical Care, vol. 45, no. 6, pp. 521–528, 2007.
[13] M. M. Engelgau, K. M. Narayan, J. B. Saaddine, and F. Vinicor,
“Addressing the burden of diabetes in the 21st century: better
care and primary prevention,” Journal of the American Society
of Nephrology, vol. 14, supplement 2, pp. S88–S91, 2003.
[14] K. M. Narayan, E. Benjamin, E. W. Gregg, S. L. Norris, and M.
M. Engelgau, “Diabetes translation research: where are we and
wher ed ow ewantt obe?”AnnalsofInternalMedicine,vol.140,
no. 11, pp. 958–963, 2004.
[15] S. Nam, C. Chesl, N. A. Stotts, L. Kroon, and L. S. Janson,
“Barriers to diabetes management: patient and provider
factors,” Diabetes Research Clinical Practice, vol. 93, pp. 1–9,
2011.
[16] E. G. Eakin, S. S. Bull, R. E. Glasgow, and M. Mason, “Reach-
ing those most in need: a review of diabetes self-man-
agement interventions in disadvantaged populations,” Dia-
betes/Metabolism Research and Reviews, vol. 18, no. 1, pp. 26–
35, 2002.
[17] D. W. Satterﬁeld, M. Volansky, C. J. Caspersen et al., “Com-
munity-based lifestyle interventions to prevent type 2 dia-
betes,” Diabetes Care, vol. 26, no. 9, pp. 2643–2652, 2003.